Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Laureate Education appoints Rick Sinkfield as CLO » 08:11
06/30/20
06/30
08:11
06/30/20
08:11
LAUR

Laureate Education

$9.91 /

+0.22 (+2.27%)

Laureate Education…

Laureate Education announced the appointment of Rick Sinkfield as chief legal officer. Sinkfield previously served as Laureate's SVP and Assistant General Counsel, Latin America. Reporting to Laureate's President and CEO, Eilif Serck-Hanssen, Mr. Sinkfield will be responsible for all global legal affairs, corporate governance, corporate compliance, and regulatory matters.Mr. Sinkfield takes over this role on July 17 from Victoria Silbey, who has held the position since September 2017. Ms. Silbey is leaving to pursue another opportunity outside the company, in a sector similar to her previous experience.

ShowHide Related Items >><<
LAUR Laureate Education
$9.91 /

+0.22 (+2.27%)

LAUR Laureate Education
$9.91 /

+0.22 (+2.27%)

06/24/20 Morgan Stanley
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley
05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
LAUR Laureate Education
$9.91 /

+0.22 (+2.27%)

  • 10
    Sep
LAUR Laureate Education
$9.91 /

+0.22 (+2.27%)

Over a week ago
Upgrade
Laureate Education upgraded to Overweight from Equal Weight at Morgan Stanley » 08:26
06/24/20
06/24
08:26
06/24/20
08:26
LAUR

Laureate Education

$10.30 /

+0.12 (+1.18%)

Morgan Stanley analyst…

Morgan Stanley analyst Javier Martinez de Olcoz Cerdan upgraded Laureate Education to Overweight from Equal Weight with a price target of $13, down from $13.50, citing relative valuation versus peers after Q1 was weaker than expected across the Latin American education space. While the sector has re-rated, it is still lagging behind Bovespa longer-term and he still sees relative value within the space, the analyst tells investors.

ShowHide Related Items >><<
LAUR Laureate Education
$10.30 /

+0.12 (+1.18%)

LAUR Laureate Education
$10.30 /

+0.12 (+1.18%)

05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
LAUR Laureate Education
$10.30 /

+0.12 (+1.18%)

LAUR Laureate Education
$10.30 /

+0.12 (+1.18%)

Over a month ago
On The Fly
Fly Intel: Wall Street's top stories for Thursday » 16:43
05/14/20
05/14
16:43
05/14/20
16:43
WFC

Wells Fargo

$24.07 /

+1.545 (+6.86%)

, GS

Goldman Sachs

$174.38 /

+2.54 (+1.48%)

, CSCO

Cisco

$43.87 /

+1.96 (+4.68%)

, NCLH

Norwegian Cruise Line

$10.74 /

+0.45 (+4.37%)

, SDC

SmileDirectClub

$7.01 /

-0.685 (-8.90%)

, ALLO

Allogene Therapeutics

$42.09 /

+11.1 (+35.82%)

, MGNX

MacroGenics

$24.93 /

-1.57 (-5.92%)

, TSM

TSMC

$52.12 /

+1.18 (+2.32%)

, AAPL

Apple

$309.56 /

+2.21 (+0.72%)

, LAUR

Laureate Education

$8.34 /

+0.655 (+8.53%)

, WIX

Wix.com

$189.39 /

+23.2 (+13.96%)

, OII

Oceaneering

$4.75 /

+0.105 (+2.26%)

, CTMX

CytomX Therapeutics

$9.20 /

-5.23 (-36.24%)

, VRTU

Virtusa

$25.20 /

-6.55 (-20.63%)

, SSYS

Stratasys

$15.15 /

-1.19 (-7.28%)

Futures for the major…

Open Full Text

ShowHide Related Items >><<
WIX Wix.com
$189.39 /

+23.2 (+13.96%)

WFC Wells Fargo
$24.07 /

+1.545 (+6.86%)

VRTU Virtusa
$25.20 /

-6.55 (-20.63%)

TSM TSMC
$52.12 /

+1.18 (+2.32%)

SSYS Stratasys
$15.15 /

-1.19 (-7.28%)

SDC SmileDirectClub
$7.01 /

-0.685 (-8.90%)

OII Oceaneering
$4.75 /

+0.105 (+2.26%)

NCLH Norwegian Cruise Line
$10.74 /

+0.45 (+4.37%)

MGNX MacroGenics
$24.93 /

-1.57 (-5.92%)

LAUR Laureate Education
$8.34 /

+0.655 (+8.53%)

GS Goldman Sachs
$174.38 /

+2.54 (+1.48%)

CTMX CytomX Therapeutics
$9.20 /

-5.23 (-36.24%)

CSCO Cisco
$43.87 /

+1.96 (+4.68%)

ALLO Allogene Therapeutics
$42.09 /

+11.1 (+35.82%)

AAPL Apple
$309.56 /

+2.21 (+0.72%)

WFC Wells Fargo
$24.07 /

+1.545 (+6.86%)

05/14/20 JPMorgan
Wells Fargo, Goldman Sachs merger speculation 'unfounded,' says JPMorgan
05/05/20 Atlantic Equities
Atlantic Equities downgrades Wells Fargo to Underweight, predicts dividend cut
05/05/20
Fly Intel: Top five analyst downgrades
05/05/20 Atlantic Equities
Wells Fargo downgraded to Underweight from Neutral at Atlantic Equities
GS Goldman Sachs
$174.38 /

+2.54 (+1.48%)

05/14/20 BMO Capital
BMO upgrades Goldman to Outperform on 'strong' capital position
05/14/20 BMO Capital
Goldman Sachs upgraded to Outperform from Market Perform at BMO Capital
04/17/20 DA Davidson
Goldman Sachs price target raised to $185 from $165 at DA Davidson
CSCO Cisco
$43.87 /

+1.96 (+4.68%)

05/14/20 Needham
Cisco recovery to be a slow process, says Needham
05/14/20 JPMorgan
Cisco fiscal Q3 results better than feared, says JPMorgan
05/14/20 Morgan Stanley
Cisco too broadly exposed to macro to be more positive, says Morgan Stanley
05/14/20 Baird
Cisco price target raised to $48 from $46 at Baird
NCLH Norwegian Cruise Line
$10.74 /

+0.45 (+4.37%)

05/15/20 JPMorgan
Norwegian Cruise Line price target lowered to $18 from $26 at JPMorgan
05/15/20 Deutsche Bank
Norwegian Cruise Line price target lowered to $11 from $14 at Deutsche Bank
05/15/20 Nomura Instinet
Norwegian risk/reward 'heavily skewed to the upside,' says Nomura Instinet
05/14/20 Stifel
Stifel sees 'ample' long-term upside in Norwegian Cruise Line
SDC SmileDirectClub
$7.01 /

-0.685 (-8.90%)

05/14/20
Fly Intel: Top five analyst downgrades
05/14/20 JPMorgan
JPMorgan 'incrementally more positive' on SmileDirectClub after earnings call
05/14/20 BofA
BofA double downgrades SmileDirectClub to Underperform on recovery worries
05/14/20 BofA
SmileDirectClub downgraded to Underperform from Buy at BofA
ALLO Allogene Therapeutics
$42.09 /

+11.1 (+35.82%)

05/15/20 Guggenheim
Allogene Therapeutics upgraded to Buy from Neutral at Guggenheim
05/14/20 Oppenheimer
Allogene Therapeutics price target raised to $50 from $44 at Oppenheimer
05/14/20 Jefferies
Jefferies raises price target on 'ASCO winner' Allogene Therapeutics to $45
05/14/20 SunTrust
Allogene Therapeutics downgraded to Hold from Buy at SunTrust
MGNX MacroGenics
$24.93 /

-1.57 (-5.92%)

05/14/20 Wedbush
MacroGenics price target raised to $28 from $16 at Wedbush
05/12/20 Credit Suisse
MacroGenics price target raised to $30 from $13 at Credit Suisse
05/06/20 H.C. Wainwright
MacroGenics price target raised to $22 from $18 at H.C. Wainwright
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
TSM TSMC
$52.12 /

+1.18 (+2.32%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Wedbush
Wedbush bullish on TSMC, initiates with an Outperform
04/27/20 Wedbush
TSMC initiated with an Outperform at Wedbush
04/17/20 Susquehanna
TSMC downgraded to Negative from Positive at Susquehanna
AAPL Apple
$309.56 /

+2.21 (+0.72%)

05/12/20 Wedbush
Apple price target raised to $350 from $335 at Wedbush
05/07/20 Bernstein
Google payments to Apple big, predicated on advertising, says Bernstein
05/06/20 Morgan Stanley
Apple's App Store just had strongest month in 2.5 years, says Morgan Stanley
05/06/20 Daiwa
Apple price target raised to $320 from $297 at Daiwa
LAUR Laureate Education
$8.34 /

+0.655 (+8.53%)

05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
WIX Wix.com
$189.39 /

+23.2 (+13.96%)

05/15/20 JPMorgan
Wix.com price target raised to $185 from $149 at JPMorgan
05/15/20 Needham
Wix.com price target raised to $220 from $165 at Needham
05/15/20 Oppenheimer
Wix.com price target raised to $205 from $155 at Oppenheimer
05/15/20 SunTrust
Wix.com price target raised to $215 from $167 at SunTrust
OII Oceaneering
$4.75 /

+0.105 (+2.26%)

04/24/20 Citi
Oceaneering upgraded to Buy from Neutral at Citi
04/05/20 Bernstein
Oceaneering upgraded to Market Perform from Underperform at Bernstein
03/19/20 Wolfe Research
Oceaneering downgraded to Peer Perform from Outperform at Wolfe Research
03/13/20 Wells Fargo
Drillers downgraded at Wells Fargo on recent sell off in commodity prices
CTMX CytomX Therapeutics
$9.20 /

-5.23 (-36.24%)

05/14/20 H.C. Wainwright
CytomX Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
05/08/20 H.C. Wainwright
CytomX Therapeutics price target raised to $16 from $14 at H.C. Wainwright
03/30/20 Piper Sandler
CytomX Therapeutics payment for CX-2029 notable milestone, says Piper Sandler
03/24/20 Wedbush
CytomX Therapeutics upgraded to Outperform at Wedbush
VRTU Virtusa
$25.20 /

-6.55 (-20.63%)

05/14/20 William Blair
Virtusa downgraded to Market Perform from Outperform at William Blair
02/07/20 Needham
Virtusa price target raised to $56 from $48 at Needham
01/07/20 Barrington
Adtalem, Tivity, Virtusa among Barrington's Best Ideas for 2020
01/06/20 Wedbush
Wedbush says buy Virtusa on weakness as market 'overreacts' to Citi renewal
SSYS Stratasys
$15.15 /

-1.19 (-7.28%)

04/27/20 Piper Sandler
Stratasys Q1 results likely to be below plan, says Piper Sandler
04/06/20 JPMorgan
Stratasys, 3D Systems losing share amid new entrants, says JPMorgan
03/24/20 Piper Sandler
Stratasys price target lowered to $20 from $24 at Piper Sandler
02/27/20 Loop Capital
Loop Capital backs Sell on 3D Systems given macro, coronavirus headwinds
WIX Wix.com
$189.39 /

+23.2 (+13.96%)

WFC Wells Fargo
$24.07 /

+1.545 (+6.86%)

VRTU Virtusa
$25.20 /

-6.55 (-20.63%)

TSM TSMC
$52.12 /

+1.18 (+2.32%)

SSYS Stratasys
$15.15 /

-1.19 (-7.28%)

SDC SmileDirectClub
$7.01 /

-0.685 (-8.90%)

OII Oceaneering
$4.75 /

+0.105 (+2.26%)

NCLH Norwegian Cruise Line
$10.74 /

+0.45 (+4.37%)

MGNX MacroGenics
$24.93 /

-1.57 (-5.92%)

LAUR Laureate Education
$8.34 /

+0.655 (+8.53%)

GS Goldman Sachs
$174.38 /

+2.54 (+1.48%)

CTMX CytomX Therapeutics
$9.20 /

-5.23 (-36.24%)

CSCO Cisco
$43.87 /

+1.96 (+4.68%)

ALLO Allogene Therapeutics
$42.09 /

+11.1 (+35.82%)

AAPL Apple
$309.56 /

+2.21 (+0.72%)

WFC Wells Fargo
$24.07 /

+1.545 (+6.86%)

TSM TSMC
$52.12 /

+1.18 (+2.32%)

SDC SmileDirectClub
$7.01 /

-0.685 (-8.90%)

NCLH Norwegian Cruise Line
$10.74 /

+0.45 (+4.37%)

GS Goldman Sachs
$174.38 /

+2.54 (+1.48%)

CSCO Cisco
$43.87 /

+1.96 (+4.68%)

AAPL Apple
$309.56 /

+2.21 (+0.72%)

WFC Wells Fargo
$24.07 /

+1.545 (+6.86%)

TSM TSMC
$52.12 /

+1.18 (+2.32%)

SDC SmileDirectClub
$7.01 /

-0.685 (-8.90%)

OII Oceaneering
$4.75 /

+0.105 (+2.26%)

NCLH Norwegian Cruise Line
$10.74 /

+0.45 (+4.37%)

MGNX MacroGenics
$24.93 /

-1.57 (-5.92%)

LAUR Laureate Education
$8.34 /

+0.655 (+8.53%)

GS Goldman Sachs
$174.38 /

+2.54 (+1.48%)

CTMX CytomX Therapeutics
$9.20 /

-5.23 (-36.24%)

CSCO Cisco
$43.87 /

+1.96 (+4.68%)

ALLO Allogene Therapeutics
$42.09 /

+11.1 (+35.82%)

AAPL Apple
$309.56 /

+2.21 (+0.72%)

WIX Wix.com
$189.39 /

+23.2 (+13.96%)

WFC Wells Fargo
$24.07 /

+1.545 (+6.86%)

TSM TSMC
$52.12 /

+1.18 (+2.32%)

SSYS Stratasys
$15.15 /

-1.19 (-7.28%)

SDC SmileDirectClub
$7.01 /

-0.685 (-8.90%)

NCLH Norwegian Cruise Line
$10.74 /

+0.45 (+4.37%)

GS Goldman Sachs
$174.38 /

+2.54 (+1.48%)

CSCO Cisco
$43.87 /

+1.96 (+4.68%)

AAPL Apple
$309.56 /

+2.21 (+0.72%)

AAPL Apple
$309.56 /

+2.21 (+0.72%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 13:06
05/14/20
05/14
13:06
05/14/20
13:06
WFC

Wells Fargo

$24.00 /

+1.475 (+6.55%)

, GS

Goldman Sachs

$171.34 /

-0.5 (-0.29%)

, CSCO

Cisco

$43.46 /

+1.545 (+3.69%)

, NCLH

Norwegian Cruise Line

$10.40 /

+0.11 (+1.07%)

, SDC

SmileDirectClub

$7.10 /

-0.595 (-7.73%)

, LAUR

Laureate Education

$8.28 /

+0.6 (+7.81%)

, WIX

Wix.com

$181.00 /

+14.81 (+8.91%)

, OII

Oceaneering

$4.87 /

+0.23 (+4.96%)

, CTMX

CytomX Therapeutics

$9.53 /

-4.9 (-33.96%)

, VRTU

Virtusa

$23.09 /

-8.66 (-27.28%)

, SSYS

Stratasys

$15.31 /

-1.03 (-6.30%)

Futures for the major…

Open Full Text

ShowHide Related Items >><<
WIX Wix.com
$181.00 /

+14.81 (+8.91%)

WFC Wells Fargo
$24.00 /

+1.475 (+6.55%)

VRTU Virtusa
$23.09 /

-8.66 (-27.28%)

SSYS Stratasys
$15.31 /

-1.03 (-6.30%)

SDC SmileDirectClub
$7.10 /

-0.595 (-7.73%)

OII Oceaneering
$4.87 /

+0.23 (+4.96%)

NCLH Norwegian Cruise Line
$10.40 /

+0.11 (+1.07%)

LAUR Laureate Education
$8.28 /

+0.6 (+7.81%)

GS Goldman Sachs
$171.34 /

-0.5 (-0.29%)

CTMX CytomX Therapeutics
$9.53 /

-4.9 (-33.96%)

CSCO Cisco
$43.46 /

+1.545 (+3.69%)

WFC Wells Fargo
$24.00 /

+1.475 (+6.55%)

05/14/20 JPMorgan
Wells Fargo, Goldman Sachs merger speculation 'unfounded,' says JPMorgan
05/05/20 Atlantic Equities
Atlantic Equities downgrades Wells Fargo to Underweight, predicts dividend cut
05/05/20
Fly Intel: Top five analyst downgrades
05/05/20 Atlantic Equities
Wells Fargo downgraded to Underweight from Neutral at Atlantic Equities
GS Goldman Sachs
$171.34 /

-0.5 (-0.29%)

04/17/20 DA Davidson
Goldman Sachs price target raised to $185 from $165 at DA Davidson
04/16/20 BMO Capital
Goldman Sachs price target raised to $205 from $168 at BMO Capital
04/16/20 Citi
Goldman Sachs remains a 'compelling buy,' says Citi
CSCO Cisco
$43.46 /

+1.545 (+3.69%)

05/14/20 Needham
Cisco recovery to be a slow process, says Needham
05/14/20 JPMorgan
Cisco fiscal Q3 results better than feared, says JPMorgan
05/14/20 Morgan Stanley
Cisco too broadly exposed to macro to be more positive, says Morgan Stanley
05/14/20 Baird
Cisco price target raised to $48 from $46 at Baird
NCLH Norwegian Cruise Line
$10.40 /

+0.11 (+1.07%)

05/13/20 Wells Fargo
Wells Fargo downgrades Norwegian Cruise Line on 'elongated' industry recovery
05/13/20 Wells Fargo
Norwegian Cruise Line downgraded to Equal Weight from Overweight at Wells Fargo
05/05/20 Goldman Sachs
Goldman says capital raise gives Norwegian runway to endure slow recovery
04/23/20 Stifel
Stifel calls Royal best positioned cruise operator, ups target to $48
SDC SmileDirectClub
$7.10 /

-0.595 (-7.73%)

05/14/20
Fly Intel: Top five analyst downgrades
05/14/20 JPMorgan
JPMorgan 'incrementally more positive' on SmileDirectClub after earnings call
05/14/20 BofA
BofA double downgrades SmileDirectClub to Underperform on recovery worries
05/14/20 BofA
SmileDirectClub downgraded to Underperform from Buy at BofA
LAUR Laureate Education
$8.28 /

+0.6 (+7.81%)

05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
WIX Wix.com
$181.00 /

+14.81 (+8.91%)

05/14/20 RBC Capital
Wix.com price target raised to $195 from $143 at RBC Capital
04/13/20 SunTrust
Wix's offering, business model will remain 'relatively durable,' says SunTrust
04/13/20 William Blair
Wix.com shareholder letter 'better than feared,' says William Blair
03/19/20 Wedbush
Wix.com price target lowered to $105 from $165 at Wedbush
OII Oceaneering
$4.87 /

+0.23 (+4.96%)

04/24/20 Citi
Oceaneering upgraded to Buy from Neutral at Citi
04/05/20 Bernstein
Oceaneering upgraded to Market Perform from Underperform at Bernstein
03/19/20 Wolfe Research
Oceaneering downgraded to Peer Perform from Outperform at Wolfe Research
03/13/20 Wells Fargo
Drillers downgraded at Wells Fargo on recent sell off in commodity prices
CTMX CytomX Therapeutics
$9.53 /

-4.9 (-33.96%)

05/14/20 H.C. Wainwright
CytomX Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
05/08/20 H.C. Wainwright
CytomX Therapeutics price target raised to $16 from $14 at H.C. Wainwright
03/30/20 Piper Sandler
CytomX Therapeutics payment for CX-2029 notable milestone, says Piper Sandler
03/24/20 Wedbush
CytomX Therapeutics upgraded to Outperform at Wedbush
VRTU Virtusa
$23.09 /

-8.66 (-27.28%)

05/14/20 William Blair
Virtusa downgraded to Market Perform from Outperform at William Blair
02/07/20 Needham
Virtusa price target raised to $56 from $48 at Needham
01/07/20 Barrington
Adtalem, Tivity, Virtusa among Barrington's Best Ideas for 2020
01/06/20 Wedbush
Wedbush says buy Virtusa on weakness as market 'overreacts' to Citi renewal
SSYS Stratasys
$15.31 /

-1.03 (-6.30%)

04/27/20 Piper Sandler
Stratasys Q1 results likely to be below plan, says Piper Sandler
04/06/20 JPMorgan
Stratasys, 3D Systems losing share amid new entrants, says JPMorgan
03/24/20 Piper Sandler
Stratasys price target lowered to $20 from $24 at Piper Sandler
02/27/20 Loop Capital
Loop Capital backs Sell on 3D Systems given macro, coronavirus headwinds
WIX Wix.com
$181.00 /

+14.81 (+8.91%)

WFC Wells Fargo
$24.00 /

+1.475 (+6.55%)

VRTU Virtusa
$23.09 /

-8.66 (-27.28%)

SSYS Stratasys
$15.31 /

-1.03 (-6.30%)

SDC SmileDirectClub
$7.10 /

-0.595 (-7.73%)

OII Oceaneering
$4.87 /

+0.23 (+4.96%)

NCLH Norwegian Cruise Line
$10.40 /

+0.11 (+1.07%)

LAUR Laureate Education
$8.28 /

+0.6 (+7.81%)

GS Goldman Sachs
$171.34 /

-0.5 (-0.29%)

CTMX CytomX Therapeutics
$9.53 /

-4.9 (-33.96%)

CSCO Cisco
$43.46 /

+1.545 (+3.69%)

WFC Wells Fargo
$24.00 /

+1.475 (+6.55%)

SDC SmileDirectClub
$7.10 /

-0.595 (-7.73%)

NCLH Norwegian Cruise Line
$10.40 /

+0.11 (+1.07%)

GS Goldman Sachs
$171.34 /

-0.5 (-0.29%)

CSCO Cisco
$43.46 /

+1.545 (+3.69%)

WFC Wells Fargo
$24.00 /

+1.475 (+6.55%)

SDC SmileDirectClub
$7.10 /

-0.595 (-7.73%)

OII Oceaneering
$4.87 /

+0.23 (+4.96%)

NCLH Norwegian Cruise Line
$10.40 /

+0.11 (+1.07%)

LAUR Laureate Education
$8.28 /

+0.6 (+7.81%)

GS Goldman Sachs
$171.34 /

-0.5 (-0.29%)

CTMX CytomX Therapeutics
$9.53 /

-4.9 (-33.96%)

CSCO Cisco
$43.46 /

+1.545 (+3.69%)

WIX Wix.com
$181.00 /

+14.81 (+8.91%)

WFC Wells Fargo
$24.00 /

+1.475 (+6.55%)

SSYS Stratasys
$15.31 /

-1.03 (-6.30%)

SDC SmileDirectClub
$7.10 /

-0.595 (-7.73%)

NCLH Norwegian Cruise Line
$10.40 /

+0.11 (+1.07%)

GS Goldman Sachs
$171.34 /

-0.5 (-0.29%)

CSCO Cisco
$43.46 /

+1.545 (+3.69%)

Hot Stocks
Laureate Education CFO buys 101K shares of common stock » 20:20
05/13/20
05/13
20:20
05/13/20
20:20
LAUR

Laureate Education

$7.68 /

-0.59 (-7.13%)

In a regulatory filing,…

In a regulatory filing, Laureate Education disclosed that its CFO Jean-Jacques Charhon bought 101.1K shares of common stock on May 11th in a transaction totaling $904K.

ShowHide Related Items >><<
LAUR Laureate Education
$7.68 /

-0.59 (-7.13%)

LAUR Laureate Education
$7.68 /

-0.59 (-7.13%)

05/11/20 BMO Capital
Laureate Education price target lowered to $16 from $21 at BMO Capital
05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
LAUR Laureate Education
$7.68 /

-0.59 (-7.13%)

LAUR Laureate Education
$7.68 /

-0.59 (-7.13%)

Recommendations
Laureate Education price target lowered to $16 from $21 at BMO Capital » 09:14
05/11/20
05/11
09:14
05/11/20
09:14
LAUR

Laureate Education

$9.11 /

+0.31 (+3.52%)

BMO Capital analyst…

BMO Capital analyst Jeffrey Silber lowered the firm's price target on Laureate Education to $16 from $21 and keeps an Outperform rating on the shares. The analyst is updating his model to reflect the 6% year-to-date enrollment decline trend due to COVID-19 and limited visibility given the potential economic impact of the pandemic, but he remains positive on Laureate as a "best-in-class" international higher education operator whose recent divestitures will help simplify its investment story.

ShowHide Related Items >><<
LAUR Laureate Education
$9.11 /

+0.31 (+3.52%)

05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
01/29/20
Laureate Education price target raised to $28 from $22 at Stifel
Earnings
Laureate Education updates FY20 guidance » 07:24
05/07/20
05/07
07:24
05/07/20
07:24
LAUR

Laureate Education

$9.35 /

-0.26 (-2.71%)

Laureate is updating its…

Laureate is updating its full-year 2020 guidance in response to the COVID-19 pandemic, as well as foreign exchange impacts, as the U.S. Dollar has strengthened significantly since February 27, 2020, the date of the Company's fourth quarter and full year 2019 earnings release. The additional unfavorable foreign currency impact for 2020 is expected to be ($250) million for Revenue, ($55) million for Adjusted EBITDA and ($28) million for Free Cash Flow, defined as operating cash flow less capital expenditures. Given the reduced visibility over its financial and operating performance due to uncertainties related to the macroeconomic impact of the COVID-19 pandemic, Laureate is updating its guidance for full-year 2020 under two scenarios, based on current foreign exchange spot rates: Scenario 1 - Assumes gradual reopening of campuses in the second half of 2020: Total enrollments estimated to be approximately 830,000 students; Revenues estimated to be in the range of $2,675 to $2,775 million; Adjusted EBITDA estimated to be in the range of $545 to $575 million; and Free Cash Flow estimated to be in the range of $160 to $180 million. Scenario 2 - Assumes COVID-19 resurgence in second half of 2020, eroding macroeconomic conditions and campuses remain closed: Total enrollments estimated to be approximately 780,000 students; Revenues estimated to be in the range of $2,575 to $2,675 million; Adjusted EBITDA estimated to be in the range of $485 to $515 million; and Free Cash Flow estimated to be in the range of $100 million to $120 million. Revenue consensus $3.11B.

ShowHide Related Items >><<
LAUR Laureate Education
$9.35 /

-0.26 (-2.71%)

05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
01/29/20
Laureate Education price target raised to $28 from $22 at Stifel
Hot Stocks
Laureate Education implements actions to reduce cash outlays, expenses » 07:23
05/07/20
05/07
07:23
05/07/20
07:23
LAUR

Laureate Education

$9.35 /

-0.26 (-2.71%)

The company said,…

The company said, "For the past five years, Laureate has invested in building capacity to deliver high-quality, digital learning experiences for its students. From fully online universities, such as Walden University, to campus-based universities offering a combination of campus-based and online learning environments, Laureate students around the world are familiar with this mode of delivery, and faculty understand the importance of harnessing the power of technology to create authentic, personal, and innovative learning experiences for students. Prior to the COVID-19 pandemic, 28% of the teaching hours across Laureate's campus-based institutions were already being taught online as we deliver our educational offerings in a hybrid delivery model emphasizing both face-to-face and online learning. This compares to just 3% in 2014 when Laureate first started to invest in the digital enablement of its campus-based institutions. This expertise allowed all of Laureate's institutions to quickly transition to fully online in a matter of weeks and resulted in minimal disruptions to students as they were able to continue their educational programs in a high-quality online learning environment. Laureate students are now taking classes in an innovative learning environment enabled by a common learning management system (LMS) platform operated across most of the Company's network universities. Our investments in digital instruction, coupled with an ongoing commitment to quality and online learning, allow Laureate to complement synchronous, real-time instruction with the benefits of high-quality, engaging student instruction delivered through asynchronous means. We are committed to serving students with innovative and effective learning tools during this crisis and beyond. Given the uncertainty that exists as to the extent and duration of the COVID-19 pandemic, Laureate has proactively implemented a number of actions to reduce cash outlays and expenses, including freezing of non-essential capital expenditures until visibility improves and a reduction of more than $100 million in operating expenses, which includes temporary reductions in compensation for its CEO, executive management and board members. If the recovery takes longer than expected, Laureate expects to take additional actions. As previously announced, Laureate's Board of Directors has authorized the Company to explore strategic alternatives for each of its business units, evaluating all potential options, including sales, spin-offs or business combinations. The rationale for embarking on the strategic review process has not changed. However, as a result of the COVID-19 pandemic and its continuing effect on market conditions, the strategic review is progressing at a slower pace than anticipated. There can be no assurance as to how long the exploration of strategic alternatives will take, that these processes will result in the completion of any transaction, or as to the values that may be realized from any potential transaction. Laureate does not intend to provide further interim updates on the progress of this review unless and until it believes disclosure is appropriate."

ShowHide Related Items >><<
LAUR Laureate Education
$9.35 /

-0.26 (-2.71%)

05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
01/29/20
Laureate Education price target raised to $28 from $22 at Stifel
Earnings
Laureate Education reports Q1 EPS 47c, consensus (45c) » 07:22
05/07/20
05/07
07:22
05/07/20
07:22
LAUR

Laureate Education

$9.35 /

-0.26 (-2.71%)

Reports Q1 revenue…

Reports Q1 revenue $528.6M, consensus $565.28M. New enrollments decreased 18%, down 6%, adjusted for the timing of semester start dates and excluding the divestiture of UniNorte Brazil in the prior year. Total enrollments decreased 5%, down 2% excluding the divestiture of UniNorte Brazil in the prior year. Eilif Serck-Hanssen, President and Chief Executive Officer, said, "Laureate's business model demonstrated resiliency in the first quarter. While the COVID-19 pandemic affected the Company's main intake cycle in the Southern Hemisphere, resulting in lower new enrollments than anticipated, solid re-enrollment performance helped mitigate the impact on total enrollments. To further enhance Laureate's already strong liquidity position, we have proactively implemented a number of actions to preserve cash, including cost reductions. We are continuing with our strategic review process to unlock value for all our stakeholders, albeit at a slower-than-anticipated pace in light of the pandemic's effect on market conditions. During these unprecedented times, Laureate is more focused than ever on the health and well-being of our students, faculty and staff while delivering on our promise of providing high-quality educational offerings. In March, we quickly leveraged our existing expertise, technologies and learning platforms to transition our more than 800,000 campus-based students to fully online learning. I want to thank our faculty and staff for their flexibility, commitment and resilience during these challenging times."

ShowHide Related Items >><<
LAUR Laureate Education
$9.35 /

-0.26 (-2.71%)

05/04/20 Stifel
Laureate Education price target lowered to $17.50 from $27 at Stifel
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
01/29/20
Laureate Education price target raised to $28 from $22 at Stifel
Recommendations
Laureate Education price target lowered to $17.50 from $27 at Stifel » 09:11
05/04/20
05/04
09:11
05/04/20
09:11
LAUR

Laureate Education

$9.20 /

-0.26 (-2.75%)

Stifel analyst Shlomo…

Stifel analyst Shlomo Rosenbaum lowered the firm's price target on Laureate Education to $17.50 from $27 after he lowered his estimates to reflect much higher currency headwinds and near-term "friction" from the COVID-19 pandemic despite the company having moved to online delivery. He thinks the company's asset sale process is significantly slowed, if not stalled completely right now, but Rosenbaum blames that on the current environment, not because of lack of interest in the assets. He keeps a Buy rating on the shares as he believes the company is fully committed to selling off the assets, although the time to realize the sales has been temporarily pushed out.

ShowHide Related Items >><<
LAUR Laureate Education
$9.20 /

-0.26 (-2.75%)

04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight at Morgan Stanley
04/08/20 Morgan Stanley
Laureate Education downgraded to Equal Weight from Overweight at Morgan Stanley
01/29/20
Laureate Education price target raised to $28 from $22 at Stifel
01/28/20 Morgan Stanley
Laureate could unlock 30%-50% more value with new strategy, says Morgan Stanley

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.